- ELOX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Eloxx Pharmaceuticals (ELOX) S-3Shelf registration
Filed: 3 Nov 06, 12:00am
EXHIBIT 23.1
INDEPENDENT AUDITOR’S CONSENT
To the Board of Directors
Senesco Technologies, Inc.
We hereby consent to the incorporation by reference in this Registration Statement of Senesco Technologies, Inc. on Form S-3 our report dated August 10, 2006, except for note 14 as to which the date is October 11, 2006, on the consolidated financial statements of Senesco Technologies, Inc. and Subsidiary as of June 30, 2006 and for each of the three years in the period then ended appearing in the Annual Report on Form 10-K for the year ended June 30, 2006. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Goldstein Golub Kessler LLP |
|
GOLDSTEIN GOLUB KESSLER LLP
New York, New York
November 3, 2006